GlobalData on MSN
Lilly to invest $6.5bn in API manufacturing facility in Texas
Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing ...
Active Pharmaceutical Ingredients (APIs), once considered a backend component of drug production, are now emerging as ...
Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness ...
The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...
Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling ...
The API and drug product facility is the first of four new manufacturing plants set to be built by Eli Lilly in the US over ...
The limited-time offer for Nework’s Prime Day deal is available until October 8, 2025. Customers interested in maximizing ...
Our Bureau, Bengaluru Monday, September 29, 2025, 14:15 Hrs [IST] ...
If fastening technology is on your shopping list, then The ASSEMBLY Show is the place to be! You’ll find numerous suppliers ...
OpenSolar, a software platform serving more than 25,000 solar installer businesses in over 160 countries, announced new ...
The alignment of President Trump’s remarks with RFK Jr.’s longstanding support for plant-based medicines highlights the ...
Keysight Technologies, Inc. (NYSE: KEYS), has expanded its end-of-line (EOL) test portfolio with the launch of the EV2020B EV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results